— Know what they know.
Not Investment Advice
Also trades as: MXCT.L (LSE) · $vol 0M

MXCT NASDAQ

MaxCyte, Inc.
1W: -2.8% 1M: +19.1% 3M: +43.4% YTD: -31.6% 1Y: -51.4% 3Y: -71.3%
$1.04
-0.02 (-1.89%)
 
Weekly Expected Move ±14.3%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Strong Buy · Power 64 · $111.4M mcap · 99M float · 0.996% daily turnover · Short 14% of daily vol

Balance Sheet Trends

Total Assets
$203M -15.4% ▼
5Y CAGR: +31.4%
Total Liabilities
$31M -6.6% ▼
5Y CAGR: +10.8%
Shareholders Equity
$171M -16.9% ▼
5Y CAGR: +38.9%
Cash & Investments
$103M -33.3% ▼
5Y CAGR: +24.3%
Total Debt
$18M -0.5% ▼
5Y CAGR: +20.8%
Net Debt
-$2M +78.5% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$48M$11M$47M$28M$20M
Short-Term Investments$207M$216M$122M$127M$83M
Cash & ST Investments$255M$227M$168M$154M$103M
Net Receivables$7M$11M$6M$5M$4M
Inventory$5M$9M$12M$9M$8M
Other Current Assets$0$2M$4M$4M$4M
Total Current Assets$270M$252M$190M$172M$118M
Property, Plant & Equip.$13M$34M$35M$30M$28M
Goodwill & Intangibles$0$0$0$0$650K
Long-Term Investments$0$0$43M$36M$53M
Other Non-Current Assets$317K$809K$388K$2M$2M
Total Non-Current Assets$14M$34M$78M$68M$84M
Total Assets$284M$287M$268M$239M$203M
— Liabilities —
Accounts Payable$2M$292K$743K$1M$1M
Short-Term Debt$0$0$0$864K$1M
Deferred Revenue$7M$0$5M$5M$4M
Other Current Liabilities$0$7M$0$8M$8M
Total Current Liabilities$16M$15M$18M$16M$14M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$450K$1M$283K$274K$263K
Total Non-Current Liabilities$6M$17M$18M$17M$17M
Total Liabilities$21M$33M$36M$33M$31M
— Equity —
Common Stock$1M$1M$1M$1M$1M
Retained Earnings-$114M-$138M-$176M-$217M-$261M
Accumulated OCI$0-$0$0$0$0
Total Stockholders Equity$263M$254M$232M$206M$171M
Total Liabilities & Equity$284M$287M$268M$239M$203M
— Key Metrics —
Total Debt$6M$16M$19M$18M$18M
Net Debt-$42M$5M-$28M-$10M-$2M
Total Investments$207M$216M$165M$162M$136M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms